Prospective Clinicogenomic Program
Public ClinicalTrials.gov record NCT04180176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Low-Interventional Study to Evaluate the Feasibility of a Prospective Clinicogenomic Program
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate the feasibility of a scalable, prospective research program for participants with metastatic non-small cell lung cancer (mNSCLC) or extensive-stage small-cell lung cancer (ES-SCLC) planning to start standard-of-care (SOC) systemic anti-cancer treatment. The study will also examine ctDNA status over the course of treatment as a predictor of response to therapy.
Study identification
- NCT ID
- NCT04180176
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 945 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 13, 2019 (Actual)
- Primary completion
- Nov 30, 2023 (Actual)
- Completion
- Nov 30, 2023 (Actual)
- Last update posted
- Jan 17, 2024
2019 – 2023
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Oncology | Birmingham | Alabama | 35205 | — |
| Clearview Cancer Institute | Huntsville | Alabama | 35805 | — |
| Ironwood Cancer & Research Centers | Chandler | Arizona | 85224 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| Florida Cancer Specialists; Department of Oncology | Fort Myers | Florida | 33901-8101 | — |
| Florida Cancer Specialist, North Region | St. Petersburg | Florida | 33705 | — |
| SCRI Florida Cancer Specialists PAN | Tallahassee | Florida | 32308 | — |
| Florida Cancer Specialists | West Palm Beach | Florida | 33401 | — |
| University Cancer & Blood Center, LLC; Research | Athens | Georgia | 30607 | — |
| Piedmont Cancer Institute, PC | Atlanta | Georgia | 30318 | — |
| Fort Wayne Med Oncology & Hematology Inc | Fort Wayne | Indiana | 46845 | — |
| Cancer & Hematology Centers of Western Michigan | Grand Rapids | Michigan | 49503 | — |
| Jackson Oncology Associates, PLLC | Jackson | Mississippi | 39202 | — |
| Southeast Nebraska Cancer Ctr | Lincoln | Nebraska | 68510 | — |
| Regional Cancer Care Associates LLC, Central Jersey Division | East Brunswick | New Jersey | 08816 | — |
| Hematology Oncology Associates of Central New York | East Syracuse | New York | 13057 | — |
| West Clinic | New York | New York | 10055 | — |
| National Translational Research Group | Port Jefferson Station | New York | 11776 | — |
| Oklahoma Cancer Specialists and Research Institute | Tulsa | Oklahoma | 74146 | — |
| SCRI Tennessee Oncology Chattanooga | Chattanooga | Tennessee | 37404 | — |
| Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Hematology Oncology Associates of Fredericksburg, Inc. | Fredericksburg | Virginia | 22408 | — |
| Virginia Cancer Institute - Richmond | Richmond | Virginia | 23236 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04180176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04180176 live on ClinicalTrials.gov.